Could simple education tame myeloma Treatment's harsh side effects?

NCT ID NCT07774988

NEW Completed Symptom relief Sponsor: Can Lafci Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This trial tests whether personalized education from a nurse can help people newly diagnosed with multiple myeloma better handle side effects from the drug bortezomib. Participants receive either standard care or two one-on-one teaching sessions covering symptoms like nerve pain, fatigue, and nausea. The study tracks how severe these symptoms become over about two months to see if education makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Individualized nurse-delivered education program
What this could lead to: If effective, this education program could become a standard part of care to help myeloma patients better manage treatment side effects and improve their quality of life.
What could go wrong: The trial is small and early, so results may not apply broadly. Education may not significantly reduce symptoms, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

Ege University Faculty of Medicine, Berna Türek Chemotherapy Center

İzmir, Istanbul, 34854, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.